Share Email Print

Journal of Biomedical Optics • Open Access

Biologically relevant photoacoustic imaging phantoms with tunable optical and acoustic properties
Author(s): William C. Vogt; Congxian Jia; Keith A. Wear; Brian S. Garra; T. Joshua Pfefer

Paper Abstract

Established medical imaging technologies such as magnetic resonance imaging and computed tomography rely on well-validated tissue-simulating phantoms for standardized testing of device image quality. The availability of high-quality phantoms for optical-acoustic diagnostics such as photoacoustic tomography (PAT) will facilitate standardization and clinical translation of these emerging approaches. Materials used in prior PAT phantoms do not provide a suitable combination of long-term stability and realistic acoustic and optical properties. Therefore, we have investigated the use of custom polyvinyl chloride plastisol (PVCP) formulations for imaging phantoms and identified a dual-plasticizer approach that provides biologically relevant ranges of relevant properties. Speed of sound and acoustic attenuation were determined over a frequency range of 4 to 9 MHz and optical absorption and scattering over a wavelength range of 400 to 1100 nm. We present characterization of several PVCP formulations, including one designed to mimic breast tissue. This material is used to construct a phantom comprised of an array of cylindrical, hemoglobin-filled inclusions for evaluation of penetration depth. Measurements with a custom near-infrared PAT imager provide quantitative and qualitative comparisons of phantom and tissue images. Results indicate that our PVCP material is uniquely suitable for PAT system image quality evaluation and may provide a practical tool for device validation and intercomparison.

Paper Details

Date Published: 17 February 2016
PDF: 11 pages
J. Biomed. Opt. 21(10) 101405 doi: 10.1117/1.JBO.21.10.101405
Published in: Journal of Biomedical Optics Volume 21, Issue 10
Show Author Affiliations
William C. Vogt, U.S. Food and Drug Administration (United States)
Congxian Jia, U.S. Food and Drug Administration (United States)
Keith A. Wear, U.S. Food and Drug Administration (United States)
Brian S. Garra, U.S. Food and Drug Administration (United States)
T. Joshua Pfefer, U.S. Food and Drug Administration (United States)

© SPIE. Terms of Use
Back to Top